Wellington Shields Capital Management, LLC Gilead Sciences, Inc. Transaction History
Wellington Shields Capital Management, LLC
- $558 Million
- Q3 2024
A detailed history of Wellington Shields Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 6,079 shares of GILD stock, worth $555,316. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,079
Previous 5,076
19.76%
Holding current value
$555,316
Previous $348,000
46.26%
% of portfolio
0.09%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
1,927Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.5 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.99 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.65 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.5 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $114B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...